Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001165527-19-000034
Filing Date
2019-04-01
Accepted
2019-03-29 21:16:14
Documents
76
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 g8673.htm 10-K 2308814
2 ex10-39.htm EX-10.39 70202
3 ex10-40.htm EX-10.40 75080
4 ex31-1.htm EX-31.1 18303
5 ex32-1.htm EX-32.1 8288
6 g1a.jpg GRAPHIC 52841
7 g2a.jpg GRAPHIC 61218
8 g3a.jpg GRAPHIC 58203
9 g4a.jpg GRAPHIC 16149
10 g5a.jpg GRAPHIC 75642
11 g6a.jpg GRAPHIC 33428
12 g7a.jpg GRAPHIC 31829
  Complete submission text file 0001165527-19-000034.txt   7346748

Data Files

Seq Description Document Type Size
13 clcs-20181231.xml EX-101.INS 1100559
14 clcs-20181231.xsd EX-101.SCH 65794
15 clcs-20181231_cal.xml EX-101.CAL 53196
16 clcs-20181231_def.xml EX-101.DEF 235641
17 clcs-20181231_lab.xml EX-101.LAB 380535
18 clcs-20181231_pre.xml EX-101.PRE 313315
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55413 | Film No.: 19718552
SIC: 2834 Pharmaceutical Preparations